Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05413811
The purpose of this study is to explore whether an anti-cancer medication (5-fluorouracil cream) placed in the vagina after a surgical excision procedure is an acceptable and useful form of treatment for cervical precancer among the woman with HIV infection.
Intervention
Placebo, 5 Fluorouracil (5 FU) Cream
Condition
Cervical Cancer, CIN2, CIN3, Human Immunodeficiency Virus, Human Papillomavirus
Investigators
Carla Chibwesha, MD, MSc, Sibusisiwe Luvuno

See list of participating sites